Zimbabwe has rejected a substantial American healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years due to Washington's demand for confidential data.
The decision came to light following a internal memorandum from December was leaked, revealing that Head of State Emmerson Mnangagwa felt the deal was "skewed".
A government representative later clarified that the United States was seeking health data for scientific study and profit while was unwilling to guarantee the resulting advantages from future vaccines.
"We must now begin the difficult and regrettable process of winding down our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the US had donated more than $1.9bn in health funding to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has urged further dialogue to secure a agreement acceptable to both sides so the nation's critical HIV programme can be sustained.
Broader Implications
This rejection comes after a comparable case in Kenya, where a court blocked a similar health funding agreement after concerns were filed about the safety of Kenyans' medical information.
After returning to office recently, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).
USAID had managed aid for the American government, but Trump claimed its expenditure was "inefficient" and his administration was seeking direct bilateral deals to boost openness and responsibility.
Based on statements, 16 African countries have so far agreed to similar health pacts, constituting more than $18.3bn in committed funds.
Specifics of the Rejected Deal
The funds for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this cooperation could have provided significant benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently on HIV treatment via American-funded initiatives," Tremont added.
However, government spokesperson Nick Mangwana said the arrangement was "unfair".
"Zimbabwe was being asked to surrender its genetic material and health information for a long time, without any equivalent assurance of access to any medical innovations – like vaccines, diagnostics, or treatments – that could result from that provided information," he stated.
"Put simply, our nation would provide the raw materials for medical research with no assurance that the resulting innovations would be available to our population should a future pandemic emerge."
Sovereignty and International Frameworks
He also said that the American exit from the World Health Organization (WHO) and its push of one-on-one deals were upending frameworks previously set up through the international health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme designed to manage potential pandemics.
"This framework is intended to ensure that when a nation contributes its information, the benefits – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the funds to develop them."
The government's concerns over the US deal "must not be interpreted as hostility towards the US," he added.
"We encourage ongoing dialogue with our US partners on how subsequent collaboration could be structured in a manner that honours the independence and interests of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the government's concerns, but urged that talks need to persist considering much of the country's Aids initiatives depended on international support.
"If specific concerns arise, including those involving information security or agreement terms, these can often be resolved through detailed discussion and negotiated safeguards," it commented.
The halted deal emphasises the ongoing challenges between receiving much-needed foreign assistance and safeguarding national sovereignty in an ever more data-driven world.